z-logo
Premium
Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital
Author(s) -
Shen Yin Zhong,
Qi Tang Kai,
Ma Jian Xin,
Jiang Xue Yan,
Wang Jiang Rong,
Xu Qing Nian,
Huang Qin,
Liu Xi Nian,
Sun Hong Qing,
Lu Hong Zhou
Publication year - 2007
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/j.1439-0507.2007.01421.x
Subject(s) - cryptococcosis , fluconazole , medicine , pneumonia , immunology , mortality rate , candida albicans , biology , antifungal , dermatology , microbiology and biotechnology
Summary Invasive fungal infections (IFIs) have become a major cause of morbidity and mortality among people with acquired immune deficiency syndrome (AIDS), however, little is known about the clinical features and prognosis of IFI in AIDS in China. This study aimed to characterise the clinical features and prognosis of IFI in AIDS patients in China. We retrospectively reviewed the records of all HIV‐infected patients at a Chinese university hospital between December 2004 and May 2006. We identified 35 patients with IFI. IFIs included thrush, oesophageal candidiasis, fungal pneumonia, cryptococcosis, penicilliosis and fungaemia, 44.4% of IFIs occurred in the digestive tract, 71.8% of IFIs occurred in patients with CD4 + T‐lymphocyte counts <100 cells mm −3 . Candida albicans accounted for 57.4% of fungal pathogens isolated. All the patients received both antiretroviral and antifungal therapy; 27 patients were cured and eight died. IFI is one of the most common opportunistic infections in AIDS patients in China. IFIs mainly occur in patients with low CD4 + T‐lymphocyte counts. The majority of IFIs occur in the digestive tract. The most common pathogen causing IFI is C. albicans . The mortality rate remains high although antiretroviral therapy and many newer antifungals are available in China.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here